A clinic's revenue depends on three things a buyer cannot take for granted: the facility licence, the clinicians who generate the patient volume, and the payer arrangements that determine what is actually collected. KGRN assesses whether each of those survives a change of ownership — because revenue that does not transfer is not value.
How is a healthcare business valued?
By establishing how much of the reported revenue would survive a change of ownership, and then applying recognised valuation methodology to that figure. Three questions drive the answer: whether the facility licence and regulatory approvals transfer or require re-application; whether the clinicians who generate patient volume would remain, and on what terms; and whether payer arrangements, insurance approvals and pricing continue unchanged. A clinic with strong reported earnings but revenue concentrated in one departing consultant is a materially different proposition from one where patients attach to the facility and the team.
Healthcare is unusual in that a buyer can acquire a business and still not acquire its earnings. These three areas explain most of that gap, and each is examined separately.
Health facilities and professionals are separately licensed, and a change of ownership can trigger requirements that are not automatic.
In many practices a substantial share of revenue attaches to specific doctors rather than to the clinic itself.
With most patient volume flowing through insurance, the payer relationship largely determines realised margin.
Healthcare revenue passes through several filters between the consultation and the bank account. A valuation has to work with what survives them.
| Element | What is examined | Why it affects value |
|---|---|---|
| Gross billing versus net revenue | Amounts billed, amounts approved, and amounts ultimately settled | Net realised revenue is the base for any earnings analysis, not gross billing |
| Claim rejections and resubmission | Rejection patterns by payer and by service, and recovery on resubmission | Indicates process quality; persistent rejections signal a fixable cost or a structural issue |
| Insurance receivable ageing | Balances by payer and by age, with provisioning adequacy tested | Frequently overstated; aged insurance balances often realise less than carried |
| Payer concentration | Share of revenue from the largest payers and network dependencies | Concentration is risk — a tariff change or delisting can reset margin |
| Tariff history | Movement in agreed rates over time and negotiating position | Determines margin durability more than volume growth in many practices |
| Cash-pay proportion | Self-pay and elective revenue, and its stability | Better margin and faster collection, but often more discretionary and price-sensitive |
| Service mix | Contribution by specialty, procedure and diagnostic revenue | A minority of services often carries the margin, changing the risk profile |
| Patient retention | Repeat visit rates, new versus returning patients, referral patterns | Repeat volume is more durable than acquisition-driven revenue |
Illustrative framework. What is examined depends on the practice, its specialties and the information available from its practice management and billing systems.
Revenue quality and licensing continuity are the first two things a serious buyer will test.
This distinction does more to determine healthcare value than any other single factor. Where patients attach to a named practitioner — common in specialties built on reputation and referral — the practice is closer to a personal professional business than to a transferable enterprise.
That does not make it unsaleable. It changes the structure: a buyer is likely to require the clinician to remain for a defined period, tie consideration to continued performance, or price the risk that a portion of revenue departs with the practitioner.
Where patients attach to the facility — through location, brand, insurance network access, diagnostics or a multi-practitioner team — earnings are considerably more transferable, and the valuation reflects that. Understanding which position a practice occupies is the analytical work; the number follows from it.
| Indicator | What it suggests about transferability |
|---|---|
| Revenue concentrated in one practitioner | Earnings may depart with them; retention terms usually become part of the deal |
| Owner is the principal clinician | Both ownership and revenue generation transfer at once — the highest-risk profile |
| Multi-practitioner team with spread | Individual departures are absorbable; earnings are more durable |
| Strong diagnostics or procedure base | Revenue attaches to the facility and equipment as much as to individuals |
| Insurance network access | Patient flow driven partly by coverage rather than personal reputation |
| Location and catchment | Convenience-led attendance is more transferable than referral-led |
General indicators. Each practice is assessed on its own patient and revenue data rather than on specialty assumptions.
The methodology is consistent across the sector. The pressure points are not.
Practitioner spread is the central question, alongside insurance network participation and lease terms. Multi-specialty operations generally transfer more readily than practices built around one reputation.
A blend of insured and elective work, with equipment and fit-out representing real capital. Patient recall systems and the split between routine and higher-value treatment drive both revenue durability and margin.
Predominantly cash-pay and discretionary, which means better margins and faster collection but greater sensitivity to economic conditions, marketing spend and individual practitioner reputation.
More capital-intensive and less practitioner-dependent, so earnings are typically more transferable. Value turns on equipment condition, throughput, referral relationships and payer tariffs.
Closer to retail economics with regulated pricing on many lines. Location, footfall, inventory quality including expiry exposure, and insurance dispensing arrangements are the principal drivers.
Staffing models and utilisation dominate. For home healthcare, nurse recruitment and retention drive capacity; for day surgery, theatre utilisation and case mix determine whether the fixed cost base is covered.
Practical considerations that shape both the analysis and how a transaction would proceed.
Health facilities in Dubai operate under the Dubai Health Authority, while those within Dubai Healthcare City are regulated under that free zone's own healthcare regulatory framework. Requirements for facility licensing, practitioner registration and change of ownership differ between them, and should be confirmed with the applicable regulator before relying on any position.
Mandatory health insurance requirements in Dubai mean a large proportion of patient volume flows through insurers. This supports demand stability but concentrates pricing power with payers, making tariff terms, network participation and claim handling central to margin rather than peripheral administrative matters.
Dubai has a substantial and growing supply of clinics across most specialties. This affects patient acquisition cost, pricing latitude and staff retention, and means forecast growth should be supported by evidence of catchment, referral relationships or differentiated service rather than by general market expansion.
Medical fit-out is expensive and largely specific to the site, so lease terms carry more weight than in many sectors. A short remaining term without clear renewal rights is a genuine risk to earnings continuity, since relocating a licensed facility involves both cost and regulatory process.
Healthcare groups frequently separate the licensed operating entity from property, equipment or management companies. Related-party pricing and intra-group arrangements are relevant to UAE Corporate Tax, and because legislation and Federal Tax Authority guidance continue to develop, positions should be confirmed against current requirements.
Disclosed pricing for private UAE healthcare transactions is scarce. Practical work therefore relies on properly analysed revenue quality, clinician attribution and payer economics rather than presenting any multiple as an observed market fact.
Facility licensing, practitioner registration, change of ownership approvals and clinical governance are matters for the applicable health regulator and for qualified legal and regulatory advisors. KGRN provides the financial and valuation analysis and reflects the regulatory position established by those advisors — it does not advise on licensing or clinical compliance itself.
Scope follows the purpose. For clinical businesses, revenue and licensing are examined before the financial statements are relied upon.
Scoping
Why the valuation is needed determines the basis applied and the documentation required, and establishes which entity holds the licence and which holds the other assets.
Regulatory
Facility licence scope and status, practitioner registrations, any conditions or outstanding items, and what a change of ownership would require — confirmed with reference to the applicable regulator.
Revenue
Attribution of revenue and margin, payer mix, tariff history, rejection and resubmission experience, and the split between insured and cash-paying volume.
Analysis
Owner-clinician remuneration adjusted to a market rate for the clinical work performed, personal expenses identified, related-party arrangements tested, and one-off items isolated.
Balance sheet
Insurance receivable ageing and provisioning, equipment condition and remaining life, fit-out, lease terms, and employee obligations including end-of-service provisioning.
Reporting
Income, market and asset approaches applied and reconciled, with sensitivity analysis on clinician retention, payer tariffs and patient volume assumptions.
Amounts billed, approved and settled are three different figures, and only the last is revenue.
Change of ownership requirements vary by regulator and are not automatic. They should be confirmed early.
Practice-level revenue tells you little if most of it attaches to one practitioner who may not stay.
Aged and rejected claims frequently realise less than carried, and provisioning is often optimistic.
Where the owner also treats patients, earnings must be adjusted for the cost of replacing that clinical work.
Medical fit-out is site-specific and costly, so a short remaining term is a real risk to earnings.
KGRN Chartered Accountants provides accounting, audit, tax, valuation and business advisory services across the UAE. Healthcare businesses are frequently valued on reported revenue and an assumed multiple, which ignores the questions that actually determine what a buyer receives — whether the licence carries over, whether the clinicians stay, and whether the billed revenue is collected.
Independent valuation across all purposes.
Transaction pricing and negotiation support.
Quality of earnings and receivable testing.
Reducing clinician dependence before a sale.
Partner buy-ins and buyouts.
Assurance over revenue and receivables.
I am the owner and the main doctor. Can my clinic still be sold?
Usually yes, though the structure of any transaction will reflect the position. Where the owner is also the principal revenue-generating clinician, a buyer is acquiring both the business and a dependency, and will typically address it through a defined transition period, deferred consideration linked to retained revenue, or a lower upfront price that prices the risk of patients leaving. The more useful point is that this is among the most improvable factors in healthcare valuation: recruiting additional practitioners, building referral relationships that route to the clinic rather than to you personally, and strengthening the diagnostic or procedural base all shift revenue attribution toward the facility. Each takes time to demonstrate in the numbers, which is why the question is better raised well before a sale is contemplated.
Practical answers for clinic owners, medical directors, investors and finance teams in Dubai and across the UAE.
By establishing net collected revenue rather than gross billing, analysing that revenue by practitioner, payer and service line, adjusting owner-clinician remuneration to a market rate, and then applying income, market and asset approaches. Licensing continuity and clinician retention are treated as valuation inputs because they determine how much of the revenue transfers.
Not automatically, and requirements differ depending on the applicable regulator — Dubai Health Authority for most Dubai facilities, and the separate framework applying within Dubai Healthcare City. A change of ownership may require application, amendment or approval. This should be confirmed with the relevant health authority early, since it affects both deal structure and timing.
Significantly. Where a large share of revenue attaches to one practitioner, a buyer faces the risk that the revenue leaves with them. This typically results in retention arrangements, deferred consideration linked to performance, or a lower price reflecting the risk. Practices with a spread of practitioners, or with strong diagnostic and procedural revenue, transfer more readily.
Because amounts billed, approved and ultimately settled are three different figures. Claims may be rejected, partially approved, or reduced on review, and some are never recovered even after resubmission. The valuation therefore works from net collected revenue, with rejection and recovery patterns examined to understand whether the gap reflects process issues or structural payer terms.
They are tested rather than accepted. Ageing is examined by payer, provisioning adequacy assessed against historical recovery, and rejected or resubmitted claims reviewed separately. Aged insurance balances commonly realise less than their carrying amount, and this is one of the more frequent adjustments in healthcare due diligence.
Generally yes. Where a large share of revenue depends on a small number of payers, a tariff reduction, network change or delisting can reset margin materially, and the practice has limited negotiating leverage. The extent depends on agreement terms, the practice's position in each network, and how readily patient volume could be replaced.
By adjusting it to what it would cost to employ a clinician to perform the same clinical work at market rates, separately from any return on ownership. Owners who draw little salary show inflated profit; those drawing well above market show the reverse. Both are normalised, and the adjustment must be supported by evidence of the clinical work actually performed.
They form part of the asset base, assessed on age, condition, utilisation and remaining life rather than at book value. Fit-out is largely site-specific and has limited realisable value if the facility relocates, which is why it is considered alongside lease security rather than as a freestanding asset.
Considerably. Medical fit-out is expensive and site-specific, and relocating a licensed facility involves regulatory process as well as capital cost. Earnings that depend on occupying a particular site carry the risk attached to that occupation, so remaining term and renewal rights are valuation inputs rather than legal details.
Not necessarily. Growth driven by a single practitioner increases concentration risk; growth in low-tariff insured volume may add revenue without adding margin. What matters is net collected revenue, its durability, and how much of it would survive a change of ownership.
Pharmacies sit closer to retail economics. Location and footfall drive volume, regulated pricing constrains margin on many lines, and inventory quality — including expiry exposure and slow-moving stock — requires specific testing. Insurance dispensing arrangements and their terms matter, but practitioner dependence is generally far lower than in clinical practices.
Only if prepared for that purpose. Tax provisions generally require market value between unconnected parties at a prescribed date, documented to support the position — relevant where a licensed operating entity, property and equipment sit in different group companies. Current requirements should be confirmed against Federal Tax Authority guidance.
Typically: reducing dependence on any single practitioner, improving claim acceptance rates and collection performance, clearing aged insurance receivables, diversifying payer mix, securing the lease, and maintaining revenue and patient data that a buyer can verify. Most take a year or more to show in the figures.
It depends on scope and how readily practice management and billing data can be extracted. Revenue attribution by practitioner and payer requires system reports that are not always routinely produced, and obtaining them is often the main determinant of timing rather than the analysis itself.
Fees reflect the purpose, the size and complexity of the practice, the number of entities and facilities, the quality of available billing and financial data, and the documentation required. KGRN provides a fee proposal after an initial discussion of the business and its purpose.
Whether you are preparing to sell, evaluating an acquisition, bringing in a partner, or planning succession in a practice you built, the useful first conversation covers your revenue profile, your clinical team and the purpose of the valuation. A KGRN advisor will help you scope the engagement appropriately.
KGRN Chartered Accountants | +971 4557 0204 | Contact Us
Avoid compliance gaps. Let UAE tax experts help you stay on track.
The UAE is moving toward mandatory e-invoicing. Start preparing your systems, data, and processes before the compliance deadline.